Evidence map›Paper›PMID 27486781›Full record

ArticleAmerican journal of human genetics2016

Isolated and Syndromic Retinal Dystrophy Caused by Biallelic Mutations in RCBTB1, a Gene Implicated in Ubiquitination.

Frauke Coppieters, Giulia Ascari, Katharina Dannhausen, Konstantinos Nikopoulos, Frank Peelman, Marcus Karlstetter, Mingchu Xu, Cécile Brachet, Isabelle Meunier, Miltiadis K Tsilimbaris and 15 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Case report: A novel intronicFrontiers in genetics · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. NovelOphthalmic genetics · 2022
    Article
  12. Article
  13. Article
  14. NovelJournal of ophthalmology · 2021
    Article
  15. Genetics of human female infertility†.Biology of reproduction · 2019
    Review
  16. Monomethyl Fumarate Protects the Retina From Light-Induced Retinopathy.Investigative ophthalmology & visual science · 2019
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 7 countries.

Frauke CoppietersCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium; pxlence BVBA, 9200 Dendermonde, Belgium. Electronic address: frauke.coppieters@ugent.be.
Giulia AscariCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium.
Katharina DannhausenDepartment of Ophthalmology, University of Cologne, 50931 Cologne, Germany.
Konstantinos NikopoulosUnit of Medical Genetics, Department of Computational Biology, University of Lausanne, 1011 Lausanne, Switzerland.
Frank PeelmanFlanders Institute for Biotechnology (VIB), Department of Medical Protein Research, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
Marcus KarlstetterDepartment of Ophthalmology, University of Cologne, 50931 Cologne, Germany; Therapeutic Research Group Ophthalmology, Bayer Pharma AG, 42096 Wuppertal, Germany.
Mingchu XuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Cécile BrachetPediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, 1000 Brussels, Belgium.
Isabelle MeunierGenetic Sensory Diseases, Centre Hospitalier Universitaire de Montpellier, 34295 Montpellier, France; Université Montpellier, 34090 Montpellier, France; INSERM U1051, Institut des Neurosciences de Montpellier, 34091 Montpellier, France.
Miltiadis K TsilimbarisDepartment of Ophthalmology, Medical School, University of Crete, 71409 Heraklion, Greece.
Chrysanthi TsikaDepartment of Ophthalmology, Medical School, University of Crete, 71409 Heraklion, Greece.
Styliani V BlazakiDepartment of Ophthalmology, Medical School, University of Crete, 71409 Heraklion, Greece.
Sarah VergultCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium.
Pietro FarinelliUnit of Medical Genetics, Department of Computational Biology, University of Lausanne, 1011 Lausanne, Switzerland.
Thalia Van LaethemCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium.
Miriam BauwensCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium.
Marieke De BruyneCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium.
Rui ChenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Thomas LangmannDepartment of Ophthalmology, University of Cologne, 50931 Cologne, Germany.
Ruifang SuiDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 100730 Beijing, China.
Françoise MeireDepartment of Ophthalmology, Hôpital Universitaire des Enfants Reine Fabiola, 1000 Brussels, Belgium.
Carlo RivoltaUnit of Medical Genetics, Department of Computational Biology, University of Lausanne, 1011 Lausanne, Switzerland.
Christian P HamelGenetic Sensory Diseases, Centre Hospitalier Universitaire de Montpellier, 34295 Montpellier, France; Université Montpellier, 34090 Montpellier, France; INSERM U1051, Institut des Neurosciences de Montpellier, 34091 Montpellier, France.
Bart P LeroyCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium; Department of Ophthalmology, Ghent University Hospital and Ghent University, 9000 Ghent, Belgium; Division of Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Elfride De BaereCenter for Medical Genetics, Ghent University and Ghent University Hospital, 9000 Ghent, Belgium. Electronic address: elfride.debaere@ugent.be.
Ghent University Hospital · BEUniversity of Cologne · DEUniversity of Crete · GRUniversity of Lausanne · CHBaylor College of Medicine · USQueen Fabiola Children's University Hospital · BEChinese Academy of Medical Sciences & Peking Union Medical College · CNGhent University · BEInserm · FRInstitute for Neurosciences of Montpellier · FR

Funding

VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
GENETICS OF EARLY ONSET RETINAL DISEASESR01EY018571 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI RUI CHEN · 2008 to 2026
$7.2M
Molecular Basis of Human Visual System DisordersR01EY022356 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI RUI CHEN · 2012 to 2026
$6.1M
FGI: Acquisition of an Illumina Genome Analyzer System for Functional Genomic ResS10RR026550 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI · 2010 to 2010
$500k
NCRR NIH HHS S10 RR026550NEI NIH HHS P30 EY002520NEI NIH HHS R01 EY018571NEI NIH HHS R01 EY022356
6 · The paper itself

Abstract

Inherited retinal dystrophies (iRDs) are a group of genetically and clinically heterogeneous conditions resulting from mutations in over 250 genes. Here, homozygosity mapping and whole-exome sequencing (WES) in a consanguineous family revealed a homozygous missense mutation, c.973C>T (p.His325Tyr), in RCBTB1. In affected individuals, it was found to segregate with retinitis pigmentosa (RP), goiter, primary ovarian insufficiency, and mild intellectual disability. Subsequent analysis of WES data in different cohorts uncovered four additional homozygous missense mutations in five unrelated families in whom iRD segregates with or without syndromic features. Ocular phenotypes ranged from typical RP starting in the second decade to chorioretinal dystrophy with a later age of onset. The five missense mutations affect highly conserved residues either in the sixth repeat of the RCC1 domain or in the BTB1 domain. A founder haplotype was identified for mutation c.919G>A (p.Val307Met), occurring in two families of Mediterranean origin. We showed ubiquitous mRNA expression of RCBTB1 and demonstrated predominant RCBTB1 localization in human inner retina. RCBTB1 was very recently shown to be involved in ubiquitination, more specifically as a CUL3 substrate adaptor. Therefore, the effect on different components of the CUL3 and NFE2L2 (NRF2) pathway was assessed in affected individuals' lymphocytes, revealing decreased mRNA expression of NFE2L2 and several NFE2L2 target genes. In conclusion, our study puts forward mutations in RCBTB1 as a cause of autosomal-recessive non-syndromic and syndromic iRD. Finally, our data support a role for impaired ubiquitination in the pathogenetic mechanism of RCBTB1 mutations.

Indexed as

AllelesAdolescentAdultAge of OnsetChildConsanguinityCullin ProteinsExomeFemaleFounder EffectGenes, RecessiveGuanine Nucleotide Exchange FactorsHaplotypesHomozygoteHumansLymphocytesCUL3 protein, humanCullin ProteinsGuanine Nucleotide Exchange FactorsNFE2L2 protein, humanNF-E2-Related Factor 2RCBTB1 protein, humanRNA, Messenger

Identifiers

PMID27486781
PMCPMC4974088
OpenAlexW2487930918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.